Sagent Pharmaceuticals Selects ProspectoRx and Clinical Pharmacology

Elsevier’s Gold Standard solutions chosen to provide current, accurate drug data and pricing

Tampa, FL, March 14, 2013 – Elsevier’s Gold Standard, a leading drug information provider, announced today that Sagent Pharmaceuticals, a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables, has selected ProspectoRx and Clinical Pharmacology to access current and accurate drug data and pricing.

Sagent Pharmaceuticals offers an extensive portfolio of injectable products that range from premix bags and prefilled syringes to single-dose and pharmacy bulk package vials. Sagent is the only company that offers products that feature PreventIV Measures packaging and labeling with distinct labels, easy-to-read drug names and strengths, and bar codes on all levels of packaging. These elements are designed to help reduce the risk of medication errors and improve patient safety. Sagent’s selection of PropsectoRx and Clinical Pharmacology underscores the commitment to excellence upon which the company was built.

“Our goal at Gold Standard is to provide our customers with the industry’s most powerful, efficient, and user-friendly tools that support the customers and patients they serve,” said Marianne Messer, President, Elsevier’s Gold Standard. “We are honored that Sagent Pharmaceuticals has selected ProspectoRx and Clinical Pharmacology to help meet their need for accurate and timely drug and pricing information.”

ProspectorRx delivers up-to-the-minute pricing data on brand-name drugs, generics, medical devices and supplies, in one Web-based solution. Data is updated with new information directly from drug companies and allows users to organize products into competing “market baskets” based on how drugs are actually used, providing data for competitive intelligence and formulary development. ProspectoRx searches are based on product names, ingredients and other criteria. “Watch lists” can be created to alert the user when prices change.

Clinical Pharmacology is an electronic drug reference solution, which provides current and comprehensive drug information to hospitals, retail pharmacies, health plans, PBMs, pharmaceutical manufacturers and academic institutions. Clinical Pharmacology helps drive improved outcomes by providing accurate, current information in the hands of physicians, pharmacists, and other clinicians as a referential and point-of-care drug information solution.

# # #

About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc., founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. Sagent has created a unique global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.

Elsevier’s Gold Standard
Based in Tampa, FL, Elsevier’s Gold Standard uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Elsevier’s Gold Standard solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Elsevier’s Gold Standard, visit www.goldstandard.com.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1 212 633 3164
c.capot@elsevier.com